Atairgin Ovarian Cancer Assay PMA Submission Anticipated By Year-End
This article was originally published in The Gray Sheet
Executive Summary
Atairgin Technologies expects to submit a premarket approval application for its lysophosphaticid acid (LPA) ovarian cancer assay by 2001, the firm reports.